Prediction of patient‐specific risk and percentile cohort risk of pathological stage outcome using continuous prostate‐specific antigen measurement, clinical stage and biopsy Gleason score

No abstract is available for this paper.

• Publication year

  2011

• Venue

  BJU International

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-410X.2010.09692.xPMID 20875091PMCID PMC3082635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of the partin nomogram for prostate cancer in a national sample.

  2010cited by this paper
• International epidemiology of prostate cancer: geographical distribution and secular trends.

  2009cited by this paper
• Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer

  2008cited by this paper
• Predictive models and prostate cancer

  2008cited by this paper
• External validation of the updated Partin tables in a cohort of North American men.

  2008cited by this paper
• The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.

  2008cited by this paper
• Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.

  2007cited by this paper
• Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.

  2007cited by this paper
• Evaluating the Predictiveness of a Continuous Marker

  2007cited by this paper
• Ethnic and racial differences in prostate stromal estrogen receptor α

  2005cited by this paper
• Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.

  2004cited by this paper
• Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.

  2004cited by this paper
• Associate Professor

  2004cited by this paper
• A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.

  2003cited by this paper
• A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.

  2003cited by this paper
• Quantitative biopsy pathology for the prediction of pathologically organ‐confined prostate carcinoma

  2003cited by this paper
• Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.

  2002cited by this paper
• Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

  2001cited by this paper
• Prediction of prostate carcinoma stage by quantitative biopsy pathology

  2001cited by this paper
• Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

  2001cited by this paper
• Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made.

  2000cited by this paper
• E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.

  1999cited by this paper
• Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma

  1997cited by this paper
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

  1997cited by this paper
• Results of radical prostatectomy in men with clinically localized prostate cancer.

  1996cited by this paper
• From the Editor-in-Chief

  1995cited by this paper
• The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

  1993cited by this paper

• Deep learning algorithm assisting diagnosis of prostate cancer extracapsular extension based on [18F]PSMA-1007 PET/CT and multiparametric MRI: A multicenter study.

  2025cites this paper
• Feasibility and accuracy of prostate cancer risk calculators in prediction of prostate cancer, extraprostatic extension as well as the risk of lymph nodes metastasis

  2023cites this paper
• Detect the early-warning signals of diseases based on signaling pathway perturbations on a single sample

  2021cites this paper
• Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging

  2021cites this paper
• Diagnostic performance of a nomogram incorporating cribriform morphology for the prediction of adverse pathology in prostate cancer at radical prostatectomy

  2020cites this paper
• A Novel Method for Constructing Classification Models by Combining Different Biomarker Patterns

  2020cites this paper
• Is Extraprostatic Extension of Cancer Predictable? A Review of Predictive Tools and an External Validation Based on a Large and a Single Center Cohort of Prostate Cancer Patients.

  2019cites this paper
• Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review

  2019cites this paper
• Reliability of the different versions of Partin tables in predicting extraprostatic extension of prostate cancer: a systematic review and meta-analysis.

  2019cites this paper
• Salvage radiation therapy after radical prostatectomy: survival analysis.

  2019cites this paper
• Association Between Guideline-Discordant Prostate Cancer Imaging Rates and Health Care Service Among Veterans and Medicare Recipients

  2018cites this paper
• Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer

  2018cites this paper
• Imaging of distant metastases of prostate cancer

  2018cites this paper
• Role of Prostate MRI in the Setting of Active Surveillance for Prostate Cancer.

  2018cites this paper
• Prediction of pathological stage based on clinical stage, serum prostate‐specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era

  2017cites this paper
• Long-term Oncologic Outcomes of Robotic-assisted Radical Prostatectomy by a Single Surgeon.

  2017cites this paper
• Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra‐prostatic extension (EPE) in prostatic carcinoma

  2016cites this paper
• Standardized procedure of robotic assisted laparoscopic radical prostatectomy from case 1 to case 1200

  2016cites this paper
• Changes in prostate cancer grading: Including a new patient‐centric grading system

  2016cites this paper
• Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.

  2016cites this paper
• ERG rearrangement as a novel marker for predicting the extra-prostatic extension of clinically localised prostate cancer.

  2016cites this paper
• Robotic-Assisted Laparoscopic Radical Prostatectomy.

  2015cites this paper
• [Surgery of prostate cancer: Technical principles and perioperative complications].

  2015cites this paper
• La chirurgie du cancer de la prostate : principes techniques et complications péri-opératoires☆

  2015cites this paper
• Nomogrammen als ondersteuningstool bij de besluitvorming in de oncologische zorg

  2015cites this paper
• Intravoxel Incoherent Motion (IVIM) MRT pelviner Lymphknoten: Stellenwert der biexponentiellen ADC-Berechnung in der Unterscheidung benigner und maligner Beckenlymphknoten

  2015cites this paper
• Validation of Nomograms Predicting Lymph Node Involvement in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection

  2014cites this paper
• A Comparison of Different Imaging Techniques for Localisation of Cancers in the Prostate

  2014cites this paper
• Development Of Trans-rectal Ultrasound (TRUS) Coupled Diffuse Optical Tomography (DOT) For Prostate Cancer Imaging

  2014cites this paper
• Vorhersage der Lateralität von Prostatakarzinomen anhand von standardisierten Prognosefaktoren bei low-risk Patienten

  2014cites this paper
• Combined PET/MRI Improves Diagnostic Accuracy in Patients with Prostate Cancer: A Prospective Diagnostic Trial

  2014cites this paper
• Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers

  2014cites this paper
• Risk Factors for Positive Surgical Margins in organ-confined Prostate Cancer treated with Robotic-assisted Radical Prostatectomy

  2013cites this paper
• Evaluation of prediction models for the staging of prostate cancer

  2013cites this paper
• An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011

  2013cites this paper
• PCA3 Testing for the Diagnosis and Management of Prostate Cancer

  2013cites this paper
• Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomy

  2013cites this paper
• The role of PSA density to predict a pathological tumour upgrade between needle biopsy and radical prostatectomy for low risk clinical prostate cancer in the modified Gleason system era.

  2013cites this paper
• Prognostic significance of patterns of seminal vesicle invasion in prostate cancer

  2013cites this paper
• Prediction of Extraprostatic Extension in Patients with Clinically Organ-Confined Prostate Cancer

  2013cites this paper
• Nuclear morphometry, nucleomics and prostate cancer progression.

  2012cites this paper
• Is testosterone treatment good for the prostate? Study of safety during long-term treatment.

  2012cites this paper
• A systematic review of the role of adjuvant and neoadjuvant pharmacotherapy in patients undergoing radical prostatectomy

  2012cites this paper
• Surgery for Prostate Cancer

  2011cites this paper